UPDATE 2-NewLink shares tumble as pancreatic cancer therapy fails

May 9 (Reuters) - Shares of NewLink Genetics Corpplunged 37 percent in extended trading on Monday after the drug
maker said its experimental pancreatic cancer immunotherapy did
not help patients...